Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2022 Sep 2;2(3):e12103.
doi: 10.1002/jcv2.12103. eCollection 2022 Sep.

Polygenic risk scores and early manifestations of attention-deficit/hyperactivity disorder

Affiliations
Editorial

Polygenic risk scores and early manifestations of attention-deficit/hyperactivity disorder

Henrik Larsson et al. JCPP Adv. .
No abstract available

Keywords: early detection; early intervention; polygenic risk scores; preschool ADHD.

PubMed Disclaimer

Conflict of interest statement

Henrik Larsson reports receiving grants from Shire Pharmaceuticals; personal fees from and serving as a speaker for Medice, Shire/Takeda Pharmaceuticals and Evolan Pharma AB; and sponsorship for a conference on attention‐deficit/hyperactivity disorder from Shire/Takeda Pharmaceuticals and Evolan Pharma AB, all outside the submitted work. Henrik Larsson is Editor‐in‐Chief of JCPP Advances. Guilherme, Guilherme V. Polanczyk reports receiving personal fees from and serving as a speaker and/or consultant for Abbott, Ache, Medice, Novo Nordisk, Takeda and royalties from Editora Manole. Guilherme V. Polanczyk is a Joint Editor for JCPP Advances.

Similar articles

References

    1. Demontis, D. , Walters, R. K. , Martin, J. , Mattheisen, M. , Als, T. D. , Agerbo, E. , Baldursson, G. , Belliveau, R. , Bybjerg‐Grauholm, J. , Bækvad‐Hansen, M. , Cerrato, F. , Chambert, K. , Churchhouse, C. , Dumont, A. , Eriksson, N. , Gandal, M. , Goldstein, J. I. , Grasby, K. L. , Grove, J. , & Neale, B. M. (2019). Discovery of the first genome‐wide significant risk loci for attention deficit/hyperactivity disorder. Nature Genetics, 51(1), 63–75. 10.1038/s41588-018-0269-7 - DOI - PMC - PubMed
    1. Farhat, L. C. , Brentani, H. , & Polanczyk, G. V. (2020). Editorial: Polygenic risk as a biomarker for attention‐deficit/hyperactivity disorder. Journal of the American Academy of Child & Adolescent Psychiatry, 59(8), 926–928. 10.1016/j.jaac.2019.11.024 - DOI - PubMed
    1. Larsson, H. (2021). Quantitative and molecular genetics of child and adolescent mental health disorders: Recent advances, knowledge gaps and directions for future research. JCPP Advances, 1, e12014. 10.1111/jcv2.12014 - DOI - PMC - PubMed
    1. Riglin, L. , Tobarra‐Sanchez, E. , Stergiakouli, E. , Havdahl, A. , Tilling, K. , O’Donovan, M. , Nigg, J. , Langley, K. , & Thapar, A. (2022). Early manifestations of genetic liability for ADHD, autism and schizophrenia at ages 18 and 24 months. JCPP Advances, e12093. 10.1002/jcv2.12093 - DOI - PMC - PubMed
    1. Ronald, A. , de Bode, N. , & Polderman, T. J. C. (2021). Systematic review: How the attention‐deficit/hyperactivity disorder polygenic risk score adds to our understanding of ADHD and associated traits. Journal of the American Academy of Child & Adolescent Psychiatry, 60(10), 1234–1277. 10.1016/j.jaac.2021.01.019 - DOI - PMC - PubMed

Publication types